ARTICLE | Company News
Nautilus, Creabilis therapeutic protein deal
September 3, 2004 7:00 AM UTC
Nautilus (Paris, France) will use its protein evolution technology to identify a variant of CT500 protein from Creabilis ( Ivrea, Italy) with an improved pharmacodynamic profile. CT500 targets HMGB1, ...